Tsumura: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery after Surgery (ERAS) Protocol in Subjects Undergoing Bowel Resection

Grants and Contracts Details

StatusActive
Effective start/end date8/19/22 → 5/15/25

Funding

  • Syneos Health LLC: $71,933.00